Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF

2015230 citationsJournal Articlehybrid Open Access

Authors

Ivan Netuka · Institute of Clinical and Experimental Medicine

Poornima Sood · St. Jude Medical Center

Yuriy Pya

Daniel Zimpfer · Medical University of Vienna

Thomas Krabatsch · Deutsches Herzzentrum der Charité

Jens Garbade · Leipzig Heart Institute

Vivek Rao · Toronto General Hospital

Abstract

The results show that the fully magnetically levitated centrifugal-flow chronic LVAS is safe, with high 30-day and 6-month survival rates, a favorable adverse event profile, and improved quality of life and functional status. (HeartMate 3™ CE Mark Clinical Investigation Plan [HM3 CE Mark]; NCT02170363).

Topics & Keywords

Mechanical Circulatory Support Devices Cardiac Structural Anomalies and Repair Cardiac Arrest and Resuscitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American College of Cardiology

Volume 66, Issue 23, pp. 2579-2589

DOI: 10.1016/j.jacc.2015.09.083

Field-Weighted Citation Impact: 23.75